Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
0.598
-0.012 (-1.90%)
At close: Feb 21, 2025, 4:00 PM
0.609
+0.011 (1.77%)
After-hours: Feb 21, 2025, 5:20 PM EST

Karyopharm Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Feb '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
7685993854861,139
Upgrade
Market Cap Growth
-13.86%-13.86%-74.26%-20.76%-57.36%-5.35%
Upgrade
Enterprise Value
2352202015495951,079
Upgrade
Last Close Price
0.600.680.863.406.4315.48
Upgrade
PS Ratio
0.500.590.682.452.3210.54
Upgrade
PB Ratio
-0.41-0.46-0.73-23.11-6.1022.54
Upgrade
P/TBV Ratio
-----22.54
Upgrade
EV/Sales Ratio
1.621.511.383.502.849.99
Upgrade
Debt / Equity Ratio
-1.44-1.44-2.27-18.72-3.944.04
Upgrade
Asset Turnover
0.720.720.490.470.680.36
Upgrade
Inventory Turnover
1.541.541.361.251.011.81
Upgrade
Quick Ratio
1.511.513.165.053.434.35
Upgrade
Current Ratio
1.701.703.375.313.744.59
Upgrade
Return on Equity (ROE)
------391.29%
Upgrade
Return on Assets (ROA)
-36.88%-36.88%-27.05%-26.79%-19.87%-35.33%
Upgrade
Return on Capital (ROIC)
-58.48%-58.48%-34.57%-33.60%-25.14%-42.72%
Upgrade
Earnings Yield
-101.16%-89.55%-144.44%-42.94%-25.54%-17.23%
Upgrade
FCF Yield
-168.95%-149.55%-93.59%-38.88%-22.09%-14.08%
Upgrade
Buyback Yield / Dilution
-11.02%-11.02%-39.51%-8.84%-4.41%-16.28%
Upgrade
Total Shareholder Return
-11.02%-11.02%-39.51%-8.84%-4.41%-16.28%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.